What To Do When the Risk Environment Is Rapidly Shifting and Heterogeneous? Anticipatory Governance and Real-Time Assessment of Social Risks in Multiply Marginalized Populations Can Prevent IRB Mission Creep, Ethical Inflation or Underestimation of Risks

American Journal of Bioethics 9 (11):65-68 (2009)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/15265160903197671

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 100,937

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Assessing Social Risks Prior to Commencement of a Clinical Trial: Due Diligence or Ethical Inflation?Scott Burris & Corey Davis - 2009 - American Journal of Bioethics 9 (11):48-54.
The Ethical Problems of the Open Label Extension Study.Kenneth Craig Micetich - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (3):410.
The Merits of Procedure-Level Risk-Benefit Assessment.Anna Westra & Inez de Beaufort - 2011 - IRB: Ethics & Human Research 33 (5):7-13.
Risk Management- Current Issues and Challenges.Nerija Banaitiene (ed.) - 2012 - Vilnius Gediminias Technical University.
A Modest Proposal.Scott Burris & Corey Davis - 2009 - American Journal of Bioethics 9 (11):3-4.
The Ethical Analysis of Risk.Charles Weijer - 2000 - Journal of Law, Medicine and Ethics 28 (4):344-361.
Challenges in a Divided Assessment of the Social Benefits and Risks of Research.David Wasserman - 2011 - American Journal of Bioethics 11 (5):12-13.
A Framework for Assessment and Management of Ethical Risks Related to Stem Cell Use in Tissue Engineering.Mircea Leabu - 2011 - Ethics in Biology, Engineering and Medicine 2 (4):333-345.
Biobanking and risk assessment: a comprehensive typology of risks for an adaptive risk governance.Kaya Akyüz, Olga Tzortzatou, Łukasz Kozera, Melanie Goisauf, Signe Mezinska, Gauthier Chassang & Michaela Th Mayrhofer - 2021 - Life Sciences, Society and Policy 17 (1):1-28.
What risks should be permissible in controlled human infection model studies?Ariella Binik - 2020 - Bioethics 34 (4):420-430.

Analytics

Added to PP
2010-09-14

Downloads
47 (#469,173)

6 months
13 (#258,769)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

A Modest Proposal.Scott Burris & Corey Davis - 2009 - American Journal of Bioethics 9 (11):3-4.

Add more citations

References found in this work

Add more references